Clinical Trials in San Francisco

Showing 3521-3540 of 6,211 trials

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

NCT00290745

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen or letrozole may fight breast cancer by blocking the use of estrogen by the tumor cells or by lowering the amount of estrogen the body makes. PURPOSE: This clinical trial is studying how well tamoxifen or letrozole work in treating women with ductal carcinoma in situ.

Breast Cancer

University of California, San Francisco79 participantsStarted Feb 2002

San Francisco, California, United States

COMPLETEDNA< 1 mile

Fluid Responsiveness Evaluation in Sepsis-associated Hypotension

NCT02837731

This study assesses the mean difference in fluid balance at ICU discharge and associated patient outcomes, based on a dynamic assessment of fluid responsiveness in septic patients with refractory hypotension in an ICU setting.

SepsisHypotension

Cheetah Medical Inc.150 participantsStarted Oct 2016

San Francisco, California, United States • Denver, Colorado, United States • Atlanta, Georgia, United States +9 more locations

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

Fluid Responsiveness Evaluation in Sepsis-associated Hypotension

Find Trials by Condition in San Francisco

Rituximab and Belimumab for Lupus Nephritis

Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Feasibility and Efficacy of a Digital Mental Health Intervention for Teen Wildfire Survivors

Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Impact of a Chewable Plant Sterol Supplement on LDL-C in A Real-World Setting

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

TRANSFIX Zenith® Transection Clinical Study

PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study

The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation

Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck